Lung Defenses



Fig. 2.1
Antiviral action of interferon: Interferon (IFN) synthesis and release are often induced by a virus infection when cellular sensors recognize their pathogen-associated molecular patterns such as double-stranded RNA or cytoplasmic DNA. This releases transcription factors that stimulate the synthesis of mRNA, and the translated IFN protein is secreted onto a neighboring cell. IFN binds to receptor on the plasma membrane of a second cell, and that binding stimulates the activation of genes encoding antiviral proteins. Two important antiviral proteins are the enzymes 2–5 oligo (A) synthetase and protein kinase R (PKR). When an IFN-stimulated cell is infected, viral protein synthesis is inhibited by a 2–5 A-activated endoribonuclease that degrades viral mRNA and by the PKR, which phosphorylates and inactivates the initiation factor eIF-2 required for viral protein synthesis (Reproduced with permission from Wiley J, Sherwood L, Woolverton C, Eds. Prescott’s Principles of Microbiology, New York: McGraw-Hill; 2008)





References



Immune Response to Infection Ch 2. (2010) In: Sherris Medical Microbiology 5th Ed. KJ Ryan and C George Ray, Eds. The McGraw Hill Co, New York, Chicago, San Francisco. pp 19–43

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Oct 16, 2016 | Posted by in RESPIRATORY | Comments Off on Lung Defenses

Full access? Get Clinical Tree

Get Clinical Tree app for offline access